Search
Search results
35 results found
A multifunctional nanoparticle as a prophylactic and therapeutic approach targeting respiratory syncytial virus.
E, Markoutsa, McGill AR, Singer A, Jadhav H, Mohapatra S, and Mohapatra SS. 2020. “A Multifunctional Nanoparticle As a Prophylactic and Therapeutic Approach Targeting Respiratory Syncytial Virus.”. Nanomedicine. 2021 Feb;32:102325. Doi: 10.1016/J.Nano.2020.102325. Epub 2020 Nov 10. PMID: 33186695.
Combination Therapy of Mithramycin A and Immune Checkpoint Inhibitor for the Treatment of Colorectal Cancer in an Orthotopic Murine Model.
R, Dutta, Khalil R, Mayilsamy K, Green R, Howell M, Bharadwaj S, Mohapatra SS, and Mohapatra S. 2021. “Combination Therapy of Mithramycin A and Immune Checkpoint Inhibitor for the Treatment of Colorectal Cancer in an Orthotopic Murine Model.”. Front Immunol. 2021 Jul 26;12:706133. Doi: 10.3389/Fimmu.2021.706133. PMID: 34381456; PMCID: PMC8350740.
Acetate-encapsulated Linolenic Acid Liposomes Reduce SARS-CoV-2 and RSV Infection.
AR, McGill, Markoutsa E, Mayilsamy K, Green R, Sivakumar K, Mohapatra S, and Mohapatra SS. 2023. “Acetate-Encapsulated Linolenic Acid Liposomes Reduce SARS-CoV-2 and RSV Infection.”. Viruses. 2023 Jun 24;15(7):1429. Doi: 10.3390/V15071429. PMID: 37515117; PMCID: PMC10385125.
Treatment with shCCL20-CCR6 nanodendriplexes and human mesenchymal stem cell therapy improves pathology in mice with repeated traumatic brain injury.
K, Mayilsamy, Markoutsa E, Das M, Chopade P, Puro D, Kumar A, Gulick D, Willing AE, Mohapatra SS, and Mohapatra S. 2020. “Treatment With ShCCL20-CCR6 Nanodendriplexes and Human Mesenchymal Stem Cell Therapy Improves Pathology in Mice With Repeated Traumatic Brain Injury.”. Nanomedicine. 2020 Oct;29:102247. Doi: 10.1016/J.Nano.2020.102247. 32 (7): 1789-1804.
Dr. Subhra Mohapatra Invents "Tumor-on-a-disc" Technology
As reported by the United States Patent and Trademark Office: Subhra Mohapatra, a researcher at the University of South Florida and fellow of the National Academy of Inventors, invented “tumor-on-a-disc" technology that enables scientists to grow tumors in the lab to help treat and understand cancer...
Contact
A mouse model of repeated traumatic brain injury-induced hearing impairment: Early cochlear neurodegeneration in the absence of hair cell loss.
C, Penn, Mayilsamy K, Zhu XX, Bauer MA, Mohapatra SS, Frisina RD, and Mohapatra S. 2023. “A Mouse Model of Repeated Traumatic Brain Injury-Induced Hearing Impairment: Early Cochlear Neurodegeneration in the Absence of Hair Cell Loss.”. Hear Res. 2023 Sep 1;436:108832. Doi: 10.1016/J.Heares.2023.108832. Epub 2023 Jun 19. PMID: 37364367.
Actinomycin D and Telmisartan Combination Targets Lung Cancer Stem Cells Through the Wnt/Beta Catenin Pathway.
R, Green, Howell M, Khalil R, Nair R, Yan J, Foran E, Katiri S, et al. 2019. “Actinomycin D and Telmisartan Combination Targets Lung Cancer Stem Cells Through the Wnt/Beta Catenin Pathway.”. Sci Rep 9, 18177 (2019). Https://Doi.org/10.1038/S41598-019-54266-Z.
Drug Discovery in the Age of Artificial Intelligence: Transformative Target-Based Approaches.
AY, Patne, Dhulipala SM, Lawless W, Prakash S, Mohapatra SS, and Mohapatra S. 2024. “Drug Discovery in the Age of Artificial Intelligence: Transformative Target-Based Approaches.”. Int J Mol Sci. 2024 Nov 14;25(22):12233. Doi: 10.3390/Ijms252212233. PMID: 39596300; PMCID: PMC11594879.